IGI Laboratories announces fourth ANDA submission in 2014 IGI Laboratories announced it has submitted another abbreviated new drug application to the FDA, which brings the company's total number of ANDA submissions in 2014 to four, with fifteen submissions now pending at the FDA.
News For IG From The Last 14 Days
Check below for free stories on IG the last two weeks.
IGI Laboratories weakness a buying opportunity, says Craig-Hallum Craig-Hallum recommends buying IGI Laboratories and is confident in the growth opportunities and expected ANDA approvals. Shares are Buy rated.
IGI Laboratories director Damian Finio resigns IGI Laboratories has accepted Damian Finio's resignation from its Board of Directors effective August 11. Mr. Finio has accepted a senior level finance position at a pharmaceutical company, and will be unable to continue in his role as Director. The company has begun a search to replace Mr. Finio on its Board.